FDA may revoke authorized claim that soy protects the heart

The U.S. Food and Drug Administration (FDA) is taking steps to revoke its health claim that soy protein protects the heart—a move that would be a first for the organization.

The FDA authorized the soy protein claim in 1999, Reuters reported this week, but studies conducted in the nearly two decades since have produced inconsistent results. The organization is now proposing a rule that would revoke the right of American companies to say soy protein is a cardiovascular protectant.

In the past, the American Heart Association has discouraged spreading the information as a national, authorized claim, saying in a 2008 comment, “Direct cardiovascular health benefit of soy protein or isoflavone supplements is minimal at best.”

The FDA said in a statement this week it might consider downgrading the authorized soy claim to a qualified health claim, which requires less scientific evidence, if the proposed rule passes.

Read the full Reuters story here:

""

After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."